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Phosphorylation of liver plasma membrane proteins by protein kinase C was studied by using the two best 
known activators of the enzyme, 12-0-tetradecanoylphorbol-13-acetate (TPA) and 1.2-diolein. While the 
effects of TPA and diolein were almost identical on two proteins and similar in magnitude on four proteins, 
the phosphorylation of an additional four proteins was increased only by TPA. We conclude that in respect 
to phosphorylation of membrane proteins, TPA and diglycerides are not fully equivalent activators of ki- 
nase C. 
12-O-Tetradecanoylphorbol I3-acetate 
1. INTRODUCTION 
The phospholipid- and calcium-dependent pro- 
tein kinase (kinase C) can be activated by both 
1,2-DG and the tumor-promoting phorbol esters 
[ 1,2]. in fact, the enzyme appears to be identical 
with the phorbol ester receptor [3-61. The 
physiological activator of the enzyme is 1,2-DG 
which accumulates transiently as a consequence of 
increased inositol lipid breakdown [7,8]. Kinase C 
is expected to be an intracellular mediator for all 
hormones which stimulate the hydrolysis of in- 
ositol lipids [9]. 
A commonly held view is that phorbol esters and 
1,2-DG should act in a similar manner and, in- 
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There are at least two possible mechanisms 
which could account for the differences between 
the effects of 1,2-DG and phorbol esters: (i) kinase 
C, as proposed in [ 181, may not be the sole target 
of phorbol esters; (ii) activation of kinase C by 
either phorbol esters or 1,2-DG does not result in 
identical phosphorylation patterns. The latter 
phenomenon was observed by one of us in intact 
S49 mouse lymphoma cells [20]. 
Abbreviations: PS, phosphatidylserine; TPA, Here, we compared the effect of TPA, a potent 
12-0-tetradecanoylphorbol 13-acetate; 1,2-DG, 1,2-dia- tumor-promoting phorbol ester, and 1,2-diolein on 
cylglycerol the kinase C-mediated phosphorylation of liver 
1,2-Diolein Protein kinase C 
deed, many cellular events are similarly induced by 
these agents [lo-161. Although 1,2-DG often has 
smaller effects than phorbol esters, this has usually 
been attributed to the relatively rapid metabolism 
of 1,2-DG in intact cells. Most recent reports, 
however, suggest that the inability of 1,2-DG to 
reproduce the effects of phorbol esters on differen- 
tiation of HL60 cells [ 171, maturation of granulosa 
cells [18] and platelet activation [19] is not due to 
its rapid metabolism. This would indicate that 
1,2-DG has a somewhat narrower range of action 
in vivo compared to phorbol esters. 
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plasma membrane proteins. The advantage of us- 
ing this system is that while it contains kinase C 
[21] and many of its substrates, one can avoid cer- 
tain complicating features of the intact cells such 
as the possible compartmentalization and 
metabolism of kinase C activators and the enzyme 
itself. We will show qualitative differences in the 
stimulatory effects of TPA and diolein on the 
phosphorylation of membrane proteins. 
2. MATERIALS AND METHODS 
2.1. Male~~a~s 
Phosphatidylserine, 1,2-diolein, TPA and his- 
tone II-S were from Sigma. Acrylamide, SDS, N, 
N,N’,N’-tetramethylethylenediamine (TEMED) 
and ammonium persulfate were bought from 
Serva. Ampholines (pH range 3.5- 10 and 5-7) 
were the product of LKB. [T-~~P]ATP (-1000 Ci/ 
mmol) was prepared by the Isotope Institute of the 
Biological Research Center (Szeged). X-ray film 
(Medifort RP) and photographic chemicals were 
from Forte Photochemical Industry (Vat, 
Hungary) and intensifying screens (Lightning plus) 
from Du Pont. 
2.2. Methods 
Female Wistar rats (150-180 g body wt) that 
had been starved overnight were used. Liver 
plasma membranes were prepared according to 
Neville [22]. 
2.2.1. 32P labelling of membrane proteins 
Protein kinase C was solubilized from plasma 
membranes by using 1 mM EGTA in a volume of 
I ml containing also 25 mM Tris-HCl (pH 7.6) and 
3 mg membrane proteins. Solubilization was per- 
formed at 4°C for 1 h by occasionally stirring the 
samples. To measure endogenous protein 
phosphorylation, 30-~1 aliquots of the above mix- 
ture were added to the assay mixture (0.1 ml final 
volume) which contained 2.5 FM [y-32P]ATP 
(20000 cpm/pmol), 10 mM MgC12, 30 mM Tris- 
HCl (pH 7.6), 20 pg PS and 2 pg 1,2-diolein (or 
50 nM TPA). Incubations were performed for 
5 min after the addition of membranes. Due to the 
relatively rapid hydrolysis of ATP by membrane- 
bound ATPases the concentration of ATP 
dropped below 5 FM by 2.5 min incubation. 
Therefore, at 2.5 min we added labelled ATP 
204 
again (in 5 ~1) to restore the original ATP concen- 
tration (both labelled and unlabelled). There was 
no further increase in protein phosphorylation 
after 5 min even if ATP was repeatedly added. In 
fact, most proteins were maximally 
phosphorylated after 1 min incubation. Incuba- 
tions were stopped and membrane proteins 
prepared for gel electrophoresis as in [23]. 
2.2.2. Two-dimensional polyacrylamide gel 
electrophoresis 
The two-dimensiona gel procedure of O’Farrell 
[24] was used with the modifications described by 
Steinberg and Coffin0 [25]. For all samples of a 
single experiment, first-dimension isoelectric 
focusing gels were loaded with equal amounts of 
proteins (90 Fg): the acid-precipitable radioactivity 
in any of the samples varied by less than 10%. Gels 
were run for 7000 V-h; second-dimension SDS- 
containing gels were 10% (w/v) in polyacrylamide. 
Labelled proteins were detected by autoradio- 
graphy of dried gels for 2-3 days at - 70°C using 
lightning plus intensifying screens. Gel patterns are 
shown with the acidic proteins to the right. The ap- 
propriate phosphoproteins were cut out and their 
radioactivity directly measured in a dioxane-based 
scintillation cocktail using an LKB liquid scintilla- 
tion spectrometer. Protein was determined ac- 
cording to Lowry et al. [26]. 
3. RESULTS 
Rat liver plasma membranes, purified by 
Nevilie’s procedure, contain kinase C activity [21]. 
The membrane-bound enzyme, however, cannot 
be induced by PS plus diolein [21] or PS plus TPA 
(unpublished) to phosphorylate exogenous sub- 
strates. As documented in fig.lc, addition of PS 
plus TPA to plasma membranes also failed to in- 
crease phosphorylation of endogenous proteins. 
Activation of membrane-bound kinase C by lipids 
and TPA usually requires the release of the enzyme 
by either EGTA [21,27,28] or detergents 129-311. 
Thus, we first pretreated the membranes with 
EGTA and then studied the phosphorylation of en- 
dogenous proteins by the solubilized kinase C. 
During the phosphorylation assay the original 
ratio of kinase C to membrane proteins was main- 
tained. As shown in fig.lb, EGTA treatment alone 
decreased the radioactivity in several spots 
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Fig.1. Effect of EGTA and PS plus TPA on the 
phosphory~ation of liver plasma membrane proteins. 
For 32P labelling of proteins, membranes were used 
without pretreatment (a) or after pretreatment with 
1 mM EGTA for 1 h at 4°C (b). In (c) 2Opg PS plus 
50 nM TPA were added to untreated membranes. From 
each sample portions (9Opg protein) containing about 
IO5 cpm acid-precipitable radioactivity were subjected to 
high-resolution two-dimensional gel electrophoresis: gels 
were dried and exposed for 2 days at -70°C using 
lighting plus intensifying screens. Open arrowheads 
indicate those proteins whose phosphorylation was 
inhibited by ECTA. 
(designated as proteins 10-15). Most probably 
they are not related to the removal of kinase C, 
since when EGTA treatment was followed by cen- 
trifugation (and the solubilized kinase C was 
discarded) addition of 0.1 mM CaClt to mem- 
branes alone restored the levels of phosphorylation 
(not shown). 
Addition of optimum concentrations of PS 
(0.2 mg/ml) plus TPA (50 nM) to the mixture of 
Table t 
Summary of the effect of TPA and 1,kdiolein on the 
phosphorylation of plasma membrane proteins 
Protein 
no. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Stimulation by 
TPA 1,2-Diolein 
+++ - 
++ ++ 
+++ +++ 
+++ +++ 
+++ +++ 
++ - 
++ 
++ + 
++ ++ 
++ - 
+ , + + and + + + indicate l-2-, 2-4- and more than 
4-fold increases in protein phosphorylation beyond basal 
level (observed in the absence of kinase C activators). 
Data are based on direct measurement of “P 
radioactivity in proteins. For this purpose, 3 gels, 
derived from 3 different experiments, were used 
membranes and solubilized kinase C resulted in in- 
creased phosphorylation of 10 proteins (fig.2b). 
When applied alone, TPA had smaller but still 
significant effects while PS had no effect at all (not 
shown). On the other hand, when optimum 
amounts of PS plus diolein (20 aglml) were added 
together (fig.2c) phosphorylation of only 6 of the 
above 10 proteins was increased. Addition of 
CaCl2, tested up to 0.1 mM, did not alter the ef- 
fects of TPA and diolein (not shown). Most prob- 
ably, activation of kinase C by these agents re- 
quires such small amounts of calcium which were 
already present even in the presence of 0.3 mM 
ECTA (the final concentration of chelator in the 
assay mixture). This is consistent with the observa- 
tion of others [32]. No effect of TPA (fig.2d) or 
diolein (not shown) was observed, however, at 
3 mM EGTA. Addition of trifluoperazine at 
50pM, a known inhibitor of kinase C [29], com- 
pletely blocked the stimulatory effects of both 
TPA and diolein (not shown). 
The effects of TPA and diolein on the 
phosphorylation of membrane proteins, derived 
from the experiment shown in fig.2 and two other 
experiments, are summarized in table 1. In the case 
of proteins 3 and 9 the stimulatory effects of 
205 
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Fig.2. Effect of PS, TPA, 1 ,Zdiolein and high concentration of EGTA on the phosphorylation of membrane proteins 
after treatment with EGTA. After treatment with 1 mM EGTA for 1 h at 4°C membranes were used for 32P labelling 
of proteins with no additions (a), in the presence of PS plus TPA (b), PS plus 1 ,Zdiolein (c) or PS plus TPA plus 3 mM 
EGTA (d). Concentrations of PS, 1,Zdiolein and TPA were 20pg/assay, 2pg/assay and 50 nM, respectively. Note 
that in a-c, the final concentration of EGTA was 0.3 mM. Samples (90 pg protein and about 7 x lo4 acid-precipitable 
cpm) were subjected to gel electrophoresis a  before and dried gels exposed for autoradiography for 2 days at - 70°C 
using lighting plus intensifying screens. Open and fiiled arrowheads indicate those proteins whose phosphorylation was 
either decreased by EGTA or increased by PS plus TPA or PS plus diolein. 
diolein and TPA were of similar extent while 
diolein, compared to TPA, had smaller but still 
clear effects on proteins 2, 4, 5 and 8. Diolein did 
not signi~cantly increase the phosphorylation of 
proteins 1,6,7 and 10 during the 5 min incubation 
period. The discrepancy between the effects of 
TPA and diolein is particularly evident in the case 
of proteins 1 and 10 whose phosphorylation is in- 
creased by TPA by 5- and 3-fold, respectively. 
4. DISCUSSION 
The present experiments demonstrate increased 
phosphorylation of 10 liver plasma membrane pro- 
teins by solubilized kinase C in the presence of PS 
and TPA. Of these proteins 6 showed increased 
phosphorylation in the presence of diolein while 
this lipid had no significant effect on the 4 other 
proteins. These results extend our previous obser- 
vations on intact S49 lymphoma cells [ZO] that 
stimmation of kinase C with TPA and diglycerides 
does not result in the same phosphorylation pat- 
tern. The significance of this observation may be 
the following. Kinase C molecules, which are pre- 
sent in the cytoplasm in varying proportions [28], 
are rapidly transferred to plasma membranes when 
the cells are treated with TPA or agents which 
elevate the internal level of diglycerides 133-361. A 
major site of kinase C action thus appears to be the 
plasma membrane. One would expect that if TPA 
and diglycerides did not induce identical 
phosphorylation patterns in the plasma membrane 
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then there would also have been differences in their 
physiological actions. Indeed, recent evidence in- 
dicates differences in the mode of actions of TPA 
and diglycerides in vivo [17-191. 
The reason for the discrepancy between the ef- 
fects of TPA and diolein on kinase C-mediated en- 
dogenous phosphorylation is not well understood 
at present. However, it may be important to recal1 
that while one part of the TPA and diglyceride 
molecules is similar (that which is probably 
recognized by the enzyme), the other is strikingly 
different (which is probably involved in interaction 
with membranes). Due to this difference, kinase C 
molecules in the presence of TPA or diolein may: 
(i) bind to different sites in the membrane, (ii) have 
different mobilities in the membranes, or (iii) have 
somewhat different substrate specificity. While 
further studies are required to distinguish among 
these possibilities it is already clear that one does 
not necessarily have to postulate additional 
mechanisms for TPA actions (not involving kinase 
C) in order to explain the somewhat narrower 
range of diglyceride action. 
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